Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Support our campaign for better treatment for people with MS.
Bedside tested ocular motor disorders in multiple sclerosis patients.
Decreased levels of repulsive guidance molecule A in association with beneficial effects of repeated intrathecal triamcinolone acetonide application in progressive multiple sclerosis patients.
Underrecognition of Sleep Disorders in Patients with Multiple Sclerosis.
Oral Administration of Lactococcus lactis Expressing Synthetic Genes of Myelin Antigens in Decreasing Experimental Autoimmune Encephalomyelitis in Rats.
MicroRNA let-7e is associated with the pathogenesis of experimental autoimmune encephalomyelitis.
Increased IL-17A but Decreased IL-27 Serum Levels in Patients with Multiple Sclerosis.
A case of hereditary diffuse leukoencephalopathy with axonal spheroids caused by a de novo mutation in CSF1R masquerading as primary progressive multiple sclerosis.
Berberine and neurodegeneration: A review of literature.
Multiple sclerosis: review of eye movement disorders and update of disease-modifying therapies.
Neuroprotection and immunomodulation by xenografted human mesenchymal stem cells following spinal cord ventral root avulsion.
Chances and challenges of retinoid X receptor gamma targeting for regenerative multiple sclerosis treatment.
Neuropharmacological Actions of Metformin in Stroke.
Coculture of Primary Motor Neurons and Schwann Cells as a Model for In Vitro Myelination.
Diffusion tensor imaging of optic nerve and optic radiation in primary chronic angle-closure glaucoma using 3T magnetic resonance imaging.
Comparison of Intelligibility Measures for Adults with Parkinson's Disease, Multiple Sclerosis and Healthy Controls.
Olig1 Acetylation and Nuclear Export Mediate Oligodendrocyte Development.
New EMA Advice for PML Prevention With Fingolimod in MS
Monitoring interferon β treatment response with magnetic resonance spectroscopy in relapsing remitting multiple sclerosis.
Supernumerary phantom limbs in ICU patients with acute inflammatory demyelinating polyneuropathy.
Estrogen Mediates Neuroprotection and Anti-Inflammatory Effects during EAE through ERα Signaling on Astrocytes But Not through ERβ Signaling on Astrocytes or Neurons.
Brain Tissue Volumes and Perfusion Change with the Number of Optic Neuritis Attacks in Relapsing Neuromyelitis Optica: A Voxel-Based Correlation Study.
Transient oscillatory dynamics of interferon beta signaling in macrophages.
Novel advances in the diagnosis and treatment of neuromyelitis optica: is there a need to redefine the gold standard?
Cognition, cognitive dysfunction, and cognitive rehabilitation in multiple sclerosis.
Pages
« first
‹ previous
…
537
538
539
540
541
542
543
544
545
…
next ›
last »